Navigation Links
Medium External Fixator

ProductsMedium External Fixator
Company Synthes, Inc.
Item Medium External Fixator
Features 
  • Double-rod frame provides increased stability and strength
  • Medium Combination Clamp connects rod to rod or pin to rod
  • Medium Multi-Pin Clamp connects pins to rods allowing parallel pin placement
  • Both clamps accept 4.0 mm through 5.0 mm diameter Schanz screws
  • Uses 8.0 mm Carbon Fiber Rods
  • Rod Attachment for Medium Multi-Pin Clamp allows second rod to be added
  • Description The Medium External Fixator has a double-rod frame, medium Combination Clamp medium Multi-Pin Clamp, and Carbon Fiber Rods. Rod Attachment for Medium Multi-Pin Clamp allows second rod to be added.
    Info Synthes, Inc.
    Customer Service: (800) 523-0322
    Web site: http://www.synthes.com

    Related medicine products :

    1. Wilder Lacrimal Dilator - Medium
    2. Symblepharon Ring - Medium
    3. Cougar Medium Footprint
    4. Medium Ocelot Stackable Cage System
    5. The Natural-Hip Family - Medium Demand Premier
    6. S.O.C. Medium
    7. S.O.B. Medium
    8. S.O.B Medium without Magnesium
    9. SB Medium
    10. Perforated Conformer (Medium 23mm)
    11. Punch, Medium 45 Right Angled Tip, 3.4 mm Straight Shaft
    ...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
    ...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
    ...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
    ...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
    Medicine Products:
    (Date:7/25/2008)... function, increases asthma risk, studies find,... A clean, fresh-smelling home may actually be bad ...g and air freshening products you use. , Recent...cts or air fresheners that contain a certain volat...zene (1,4 DCB), can reduce lung function by 4 perc...
    (Date:7/25/2008)...an Society for Gastrointestinal Endoscopy (ASGE) h...he bariatric surgery patient. The rising prevalenc...in surgical interventions led to a marked increase...in the U.S., from 13,365 in 1998 to 102,794 in 200...ative patient and the postoperative patient, and a...
    (Date:7/25/2008)...ity.com announces the,availability of Trade Alerts... all of the daily trading notes for free by visiti...erts include: DUSA Pharmaceuticals Inc. (Nasdaq: ... MBRK ), NovaMed Inc. (Nasdaq:,NOVA), Adolor Corp....) and,Abaxis Inc. (Nasdaq: ABAX )., Join investo...
    (Date:7/25/2008)...Annual Physician On-Call Pay ...-- Sullivan, Cotter and Associates, Inc.,has publi... pay rates and,practices, the 2008 Physician On-ca... from 132 healthcare organizations nationwide, out...id for 33 physician specialty areas along,with dat...
    Breaking Medicine News(10 mins):Health News:Health Hazards in Household Cleaners Exposed 2Health News:Health Hazards in Household Cleaners Exposed 3Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 2Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 3Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 2Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 3
    ... designed a closed circuit, where Umbilical cord b...med, in order to reduce the contamination risk and...findings appear in the journal Blood Cells, Molecu... August 2005)Umbilical cord blood is a source of h...
    ...is currently the buzz word of Indian healthcare, N...nd Canada for niche high cost orthopedics surgerie...t. // The fact that surgeries by many Indian doct...ve wide experience helps to win over the confidenc...
    ...duced which has been found to have less side effec... Immunotherapy vaccines. //Antibodies against the ...ient encounters the allergen or infection these an... to counteract the allergen which is an antigen. ...
    ... have discovered that daily consumption of pomegra...schemia in patients who have coronary heart diseas... antioxidants such as soluble polyphenols, tannins...riting in the September issue of The American Jour...
    Other Medicine News:Health News:A Novel System For Clinical Banking Of Umbilical Cord Blood 2Health News:India - Favored Orthopedics Surgery Destination 2Health News:India - Favored Orthopedics Surgery Destination 3Health News:Oral Edible vaccine for Allergy Vaccines 2
    (Date:7/24/2008)...ows Increased Muscle and Blood Vessel Formation in...ISE, Fla., July 24 /- Resul...of myoblasts modified to express,stromal derived f...e of the,myocardium of rats, which suggest improve...cientific meetings -- the International Society fo...
    (Date:7/24/2008)...ment Program Speeds Oncology Patient Accrual, DEN...esearch Management,Organization (RMO), has contrac...provide research and site management services for ... enrollment strategy. The new,trials include the f...in,s,Lymphoma, Metastatic Breast Cancer, Metastati...
    (Date:7/23/2008)...Approved Systemic Therapy to Treat the Disease -, ...wswire-FirstCall/ --,Bayer HealthCare Pharmaceutic...today announced that The New England Journal of Me...trating that Nexavar(R) (sorafenib),tablets decrea...tients with,unresectable hepatocellular carcinoma ...
    (Date:7/23/2008)...Newswire/ -- FluoroPharma Inc., a company developi...ositron Emission Tomography,(PET) market, announce...uorine-18 labeled tracer for myocardial perfusion ...ular product to complete Phase I clinical,developm...ssess the blood flow in the,heart (myocardial perf...
    Breaking Medicine Technology:Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 2Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 3Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 4Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 5Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 6Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 3The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 4The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 5The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 6FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 2FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 3TeamStaff Inc Announces Results From Annual Meeting of Shareholders 17160 1TeamStaff Inc Announces Results From Annual Meeting of Shareholders 17160 2TeamStaff Inc Announces Results From Annual Meeting of Shareholders 17160 3Young Innovations Inc Provides First Quarter Conference Call Details 17158 1Young Innovations Inc Provides First Quarter Conference Call Details 17158 2Immucor CEOs Italian Trial Moves Toward Second Phase 4694 1Immucor CEOs Italian Trial Moves Toward Second Phase 4694 2Immucor CEOs Italian Trial Moves Toward Second Phase 4694 3Medivations Dimebon 28TM 29 Significantly Improved Thinking and Memory in Alzheimers Disease Patients Over One Year 1846 1Medivations Dimebon 28TM 29 Significantly Improved Thinking and Memory in Alzheimers Disease Patients Over One Year 1846 2Medivations Dimebon 28TM 29 Significantly Improved Thinking and Memory in Alzheimers Disease Patients Over One Year 1846 3Medivations Dimebon 28TM 29 Significantly Improved Thinking and Memory in Alzheimers Disease Patients Over One Year 1846 4
    ...ete Response or Reduction of,Lesion Size by More t... /PRNewswire-FirstCall/ - Nventa,Biopharmaceutical...positive results from a clinical trial examining t...investigational therapeutic,vaccine for human papi...he highest grade of cervical dysplasia (CIN III). ...
    ... 5, 2007 - Advanced Cell,Technology, Inc.,s (OTCBB... noted in Scientific American,s March 2007 issue a...l text of the article,which notes Advanced Cell,s...o transplantable retinal pigment epithelial (RPE),...ompany announced,its collaboration with the Casey ...
    Other Medicine Technology:Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 2Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 3Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 4Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 5Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 6Advanced Cell Technology's Ability to Rescue Vision in Blind Rats,Noted in Scientific American 2Advanced Cell Technology's Ability to Rescue Vision in Blind Rats,Noted in Scientific American 3